Exploration and Application of Intelligent Difficult Airway Assessment Scheme

Launched by MIN SU · Oct 2, 2024

Keywords

ClinConnect Summary

This clinical trial is studying a new way to assess difficult airways in patients who need general anesthesia. Managing difficult airways is very important because if not handled correctly, it can lead to serious complications during surgery. Currently, doctors use specific methods to evaluate airways, but these can sometimes be inaccurate. The trial is testing an intelligent assessment system that uses advanced technology to analyze images of the patient's mouth and predict how difficult their airway might be. This could help improve safety and outcomes during anesthesia.

To participate in this study, you must be at least 18 years old and scheduled for elective surgery that requires general anesthesia. You should be in good health, classified as ASA Class I, II, or III, and willing to sign a consent form to join the trial. However, if you have any airway deformities, mental health issues that affect cooperation, or are pregnant, you won't be eligible. If you join, you can expect to undergo a new assessment method that aims to provide more accurate results, contributing to better airway management in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age ≥18 years, with no gender restrictions;
• • Subjects who are scheduled to undergo elective general anesthesia and require endotracheal intubation;
• • Subjects classified as American Society of Anesthesiologists Physical Status (ASA-PS) Class I, II, and III;
• • Volunteers who are willing to participate in this clinical trial and have signed the Informed Consent Form.
• Exclusion Criteria:
• • Subjects with known airway deformities, tumors, or other structural abnormalities that may affect airway assessment;
• • Subjects with psychiatric disorders or other conditions that prevent cooperation;
• • Pregnant or lactating women;
• • Subjects who have participated in other interventional clinical trials within 1 month prior to the start of this trial;
• • Subjects deemed inappropriate to participate in this clinical trial by the investigator.